BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12236836)

  • 1. An evaluation of the Man to Man self-help group in Colorado and Utah.
    Smith RL; Crane LA; Byers T; Nelson-Marten P
    Cancer Pract; 2002; 10(5):234-9. PubMed ID: 12236836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Man to Man prostate cancer support groups.
    Coreil J; Behal R
    Cancer Pract; 1999; 7(3):122-9. PubMed ID: 10352074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of perspectives on prostate cancer: analyses of survey data.
    Crawford ED; Bennett CL; Stone NN; Knight SJ; DeAntoni E; Sharp L; Garnick MB; Porterfield HA
    Urology; 1997 Sep; 50(3):366-72. PubMed ID: 9301699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
    Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
    Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)].
    Groeben C; Baunacke M; Borkowetz A; Kliesch S; Wülfing C; Ihrig A; Huber J
    Urologe A; 2016 Jun; 55(6):784-91. PubMed ID: 26969330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.
    Radhakrishnan A; Grande D; Mitra N; Bekelman J; Stillson C; Pollack CE
    Cancer; 2017 May; 123(6):1027-1034. PubMed ID: 28263389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Man to man and side by side, they cope with prostate cancer: self-help and social support.
    Arrington MI; Grant CH; Vanderford ML
    J Psychosoc Oncol; 2005; 23(4):81-102. PubMed ID: 16618689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Men with Prostate Cancer Choose Specialists: A Qualitative Study.
    Jiang T; Stillson CH; Pollack CE; Crossette L; Ross M; Radhakrishnan A; Grande D
    J Am Board Fam Med; 2017; 30(2):220-229. PubMed ID: 28379829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current decision-making in prostate cancer therapy.
    Cox J; Amling CL
    Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
    Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
    Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
    Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of a professionally led support group for men with prostate cancer.
    Grégoire I; Kalogeropoulos D; Corcos J
    Urol Nurs; 1997 Jun; 17(2):58-66. PubMed ID: 9239139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a support program for prostate cancer survivors in Alaska.
    Kelley S; DeCourtney C; Thorsness J
    Int J Circumpolar Health; 2015; 74():28605. PubMed ID: 26612829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
    Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
    Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
    Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
    Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer support groups: Canada-based specialists' perspectives.
    Oliffe JL; Chambers S; Garrett B; Bottorff JL; McKenzie M; Han CS; Ogrodniczuk JS
    Am J Mens Health; 2015 Mar; 9(2):163-72. PubMed ID: 25061087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.
    Kim SP; Knight SJ; Tomori C; Colella KM; Schoor RA; Shih L; Kuzel TM; Nadler RB; Bennett CL
    Cancer Invest; 2001; 19(7):684-91. PubMed ID: 11577809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.